BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23211763)

  • 1. Antibacterial activity of probiotic candidates for oral health.
    Samot J; Badet C
    Anaerobe; 2013 Feb; 19():34-8. PubMed ID: 23211763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria.
    Kang MS; Oh JS; Lee HC; Lim HS; Lee SW; Yang KH; Choi NK; Kim SM
    J Microbiol; 2011 Apr; 49(2):193-9. PubMed ID: 21538238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds.
    Kang MS; Kim BG; Chung J; Lee HC; Oh JS
    J Clin Periodontol; 2006 Mar; 33(3):226-32. PubMed ID: 16489950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens.
    Chen YT; Hsieh PS; Ho HH; Hsieh SH; Kuo YW; Yang SF; Lin CW
    Lett Appl Microbiol; 2020 Apr; 70(4):310-317. PubMed ID: 31955445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifidobacteria inhibit the growth of Porphyromonas gingivalis but not of Streptococcus mutans in an in vitro biofilm model.
    Jäsberg H; Söderling E; Endo A; Beighton D; Haukioja A
    Eur J Oral Sci; 2016 Jun; 124(3):251-8. PubMed ID: 27061393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study on the Characteristics of Weissella cibaria CMU and Probiotic Strains for Oral Care.
    Jang HJ; Kang MS; Yi SH; Hong JY; Hong SP
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27999400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of oral lactobacilli as potential probiotics for oral health.
    Kõll P; Mändar R; Marcotte H; Leibur E; Mikelsaar M; Hammarström L
    Oral Microbiol Immunol; 2008 Apr; 23(2):139-47. PubMed ID: 18279182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Lactobacillus salivarius WB21 combined with green tea catechins on dental caries, periodontitis, and oral malodor.
    Higuchi T; Suzuki N; Nakaya S; Omagari S; Yoneda M; Hanioka T; Hirofuji T
    Arch Oral Biol; 2019 Feb; 98():243-247. PubMed ID: 30530235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
    Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli--an in vitro study.
    Hasslöf P; Hedberg M; Twetman S; Stecksén-Blicks C
    BMC Oral Health; 2010 Jul; 10():18. PubMed ID: 20598145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and biochemical characterizations of human oral lactobacilli as putative probiotic candidates.
    Strahinic I; Busarcevic M; Pavlica D; Milasin J; Golic N; Topisirovic L
    Oral Microbiol Immunol; 2007 Apr; 22(2):111-7. PubMed ID: 17311634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic interactions among Fusobacterium nucleatum and Prevotella intermedia with oral lactobacilli.
    Testa MM; Ruiz de Valladares R; Benito de Cardenas IL
    Res Microbiol; 2003 Dec; 154(10):669-75. PubMed ID: 14643404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
    Jansen PM; Abdelbary MMH; Conrads G
    PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of lactoferrin on oral bacterial attachment.
    Arslan SY; Leung KP; Wu CD
    Oral Microbiol Immunol; 2009 Oct; 24(5):411-6. PubMed ID: 19702956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and in vitro properties of oral lactobacilli in breastfed infants.
    Vestman NR; Timby N; Holgerson PL; Kressirer CA; Claesson R; Domellöf M; Öhman C; Tanner AC; Hernell O; Johansson I
    BMC Microbiol; 2013 Aug; 13():193. PubMed ID: 23945215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cecropin-XJ on growth and adherence of oral cariogenic bacteria in vitro.
    Hao YQ; Zhou XD; Xiao XR; Lu JJ; Zhang FC; Hu T; Wu HK; Chen XM
    Chin Med J (Engl); 2005 Jan; 118(2):155-60. PubMed ID: 15667802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of oral Lactobacillus against oral pathogens.
    Teanpaisan R; Piwat S; Dahlén G
    Lett Appl Microbiol; 2011 Oct; 53(4):452-9. PubMed ID: 21801186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of periodontal disease-associated bacteria in the "plaque-free zone".
    Noiri Y; Ebisu S
    J Periodontol; 2000 Aug; 71(8):1319-26. PubMed ID: 10972648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria.
    Yang KM; Kim JS; Kim HS; Kim YY; Oh JK; Jung HW; Park DS; Bae KH
    Sci Rep; 2021 Jan; 11(1):1631. PubMed ID: 33452304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition between yogurt probiotics and periodontal pathogens in vitro.
    Zhu Y; Xiao L; Shen D; Hao Y
    Acta Odontol Scand; 2010 Sep; 68(5):261-8. PubMed ID: 20491536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.